Success Story

IBA partners with Penn Medicine to develop flash therapy

IBA, a company developing and marketing particle accelerator technology worldwide, partnered with a team of faculty from Radiation Oncology at Penn Medicine led by James Metz, MD, Chair and Professor of Radiation Oncology, to advance research in ConformalFLASH®, a novel method combining ultra-high dose rate of proton FLASH radiotherapy and the unique Bragg Peak properties of protons. This new initiative represents another important milestone in the long-term collaboration between IBA and Penn and it has the potential to deliver a true paradigm shift in radiation therapy and cancer treatment.

Skip to content